| Targeting crosstalk between Nrf-2, NF-κB and androgen receptor signaling in prostate cancer N Khurana, SC Sikka Cancers 10 (10), 352, 2018 | 78 | 2018 |
| Interplay between SOX9, Wnt/β-catenin and androgen receptor signaling in castration-resistant prostate cancer N Khurana, SC Sikka International journal of molecular sciences 20 (9), 2066, 2019 | 62 | 2019 |
| Differential expression of novel biomarkers (TLR‐2, TLR‐4, COX‐2, and Nrf‐2) of inflammation and oxidative stress in semen of leukocytospermia patients S Hagan, N Khurana, S Chandra, AB Abdel‐Mageed, D Mondal, ... Andrology 3 (5), 848-855, 2015 | 46 | 2015 |
| Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant … N Khurana, H Kim, PK Chandra, S Talwar, P Sharma, AB Abdel-Mageed, ... Oncology reports 38 (5), 2774-2786, 2017 | 43 | 2017 |
| IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer Q Li, Y Chen, D Zhang, J Grossman, L Li, N Khurana, H Jiang, ... JCI insight 4 (19), 2019 | 34 | 2019 |
| Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway PK Chandra, SL Gerlach, C Wu, N Khurana, LT Swientoniewski, ... Scientific reports 8 (1), 14702, 2018 | 32 | 2018 |
| Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells N Khurana, S Talwar, PK Chandra, P Sharma, AB Abdel-Mageed, ... International Journal of Oncology 49 (4), 1609-1619, 2016 | 25 | 2016 |
| Bardoxolone-methyl (CDDO-me) suppresses androgen receptor and its splice-variant AR-V7 and enhances efficacy of enzalutamide in prostate cancer cells N Khurana, PK Chandra, H Kim, AB Abdel-Mageed, D Mondal, SC Sikka Antioxidants 9 (1), 68, 2020 | 24 | 2020 |
| TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations PB Dodhiawala, N Khurana, D Zhang, Y Cheng, L Li, Q Wei, K Seehra, ... The Journal of clinical investigation 130 (9), 4771-4790, 2020 | 21 | 2020 |
| Deciphering the role of innate immune NF-ĸB pathway in pancreatic cancer N Khurana, PB Dodhiawala, A Bulle, KH Lim Cancers 12 (9), 2675, 2020 | 19 | 2020 |
| Pre-exposure to stress-inducing agents increase the anticancer efficacy of focused ultrasound against aggressive prostate cancer cells HY Murad, PK Chandra, CA Kelly, N Khurana, H Yu, EP Bortz, SN Hong, ... Antioxidants 11 (2), 341, 2022 | 5 | 2022 |
| Bioremediation of tannery chromium: A microbial approach AK Gupta, D Ganjewala, N Goel, N Khurana, S Ghosh, A Saxena Research Journal of Pharmacy and Technology 7 (1), 118-122, 2014 | 4 | 2014 |
| Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors E Khlebus, VK Vuttaradhi, T Welte, N Khurana, J Celestino, HC Beird, ... Molecular Cancer Research 21 (5), 483-494, 2023 | 2 | 2023 |
| Zellregulatoren gegen Krebs: Granatapfel, Curcuma, Brokkoli LM Jacob Deutsche Zeitschrift für Onkologie 49 (04), 162-173, 2017 | 2 | 2017 |
| Low dose dimethyl sulfoxide (DMSO) downregulates the expression of androgen receptor (AR) and ar-variant 7 (AR-V7) in castration resistant prostate cancer (CRPC) cells N Khurana, H Kim, T Khan, S Kahhal, A Bukvic, AB Abdel-Mageed, ... Cancer Research 82 (12_Supplement), 2446-2446, 2022 | 1 | 2022 |
| Tumor microenvironment composition correlates with relapse in ovarian granulosa cell tumors E Khlebus, VK Vuttaradhi, T Welte, N Khurana, J Celestino, HC Beird, ... Cancer Research 83 (7_Supplement), 2503-2503, 2023 | | 2023 |
| Comparative Transcriptomic Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors E Khlebus, VK Vuttaradhi, T Welte, N Khurana, J Celestino, HC Beird, ... | | 2022 |
| Oncogenic Foxl2 is a chromatin-remodeling pioneer transcription factor in adult-type ovarian granulosa cell tumors VK Vuttaradhi, E Khlebus, T Welte, N Khurana, RT Hillman | | 2022 |
| Essential role of IRAK4/TPL2 signaling axis in MAPK activation by oncogenic RAS and genotoxic stress PB Dodhiawala, N Khurana, D Zhang, Y Cheng, L Li, K Seehra, H Jiang, ... Cancer Research 80 (16_Supplement), 3039-3039, 2020 | | 2020 |
| Bardoxolone-methyl suppresses both androgen receptor and its splice-variant ARv7 in prostate cancer cells to enhance the anti-cancer efficacy of enzalutamide N Khurana, P Chandra, H Kim, AB Abdel-Mageed, S Sikka, D Mondal Cancer Research 78 (13_Supplement), 4809-4809, 2018 | | 2018 |
